Skip to main content
. 2014 Oct 3;9(10):e109490. doi: 10.1371/journal.pone.0109490

Table 1. Sleep quality and legal drug consumption before, during and after an exam period.

Pre-Baseline ExamPeriod Post-Baseline Friedman’s Statistic
n n = 139 n = 122 n = 117 (df = 2, n = 106)
Variable Mean ± SD X2 F, Post-Hoc
Pittsburgh Sleep Quality Index (PSQI):
Bedtime (Daytime ± h) 23∶47±1.11 23∶50±1.32 00∶01±1.70
Waketime (Daytime ± h) 08∶06±1.25 07∶58±1.42 08∶40±2.66
Time in Bed (h) 8.31±0.96 8.14±1.11 8.65±1.22 12.54** B**
Sleep Onset Latency (min) 19.6±23.0 24.3±21.8 17.8±18.5 20.50*** B**
% of Cases with Sleep Onset Latency ≥30 min 22.3% 34.4% 18.8%
Reported Sleep Time (h) 7.35±1.01 7.10±1.04 7.84±1.21 17.53*** B**
Sleep Efficiency Sub-Scale 0.42±0.68 0.57±0.96 0.37±0.85 5.42n.s
Sleep Efficiency in % 88.7±0.1% 87.9±0.1% 90.6±0.1% 13.99** B*, C*
Subjective Sleep Quality 0.43±0.68 0.57±0.96 0.37±0.85 40.75*** A**, B***
% of Cases with Very Good/Fairly Good/FairlyBad/Very Bad Sleep Quality 27.3/61.2/10.1/1.4% 7.4/66.4/23.0/3.3% 31.6/62.4/5.1/0.9%
Hypnotics use: 0.02±0.15 0.04±0.27 0.02±0.18 – not enough cases
Daytime Dysfunction/Sleepiness Score 1.03±0.75 1.28±0.75 0.81±0.73 28.19 *** B ***, C *
Sleep Disturbance Sub-Scale 0.99±0.32 0.97±0.34 0.90±0.40 3.85
PSQI Global Score 4.95±2.53 6.25±2.82 4.10±2.39 47.43 *** A ***, B ***, C *
% of Cases with PSQI >5 34.5% 53.3% 21.4%
Additional Sleep Scales:
Regensburg Insomnia Scale (RIS) 7.12±4.93 8.79±5.51 6.24±3.96 29.06*** A**, B***
Legal Drug Consumption and Current Health Status (Self-report):
Caffeine (Cups) 4.76±5.67 7.10±9.51 4.56±5.52 25.88 *** A **, B **
Nicotine (Cigarettes) 7.24±25.54 7.19±29.12 5.39±20.75 0.45 n.s.
Alcohol (drinks) 5.94±6.31 3.42±4.42 6.29±7.88 19.16 *** A **, B *
% of Cases with Acute Infections, Injuries,or Exacerbations of Pre-Existing Conditions 18.7 8.2 18.8
Perceived Stress
Perceived Stress Scale (PSQ-20) 33.68±17.62 54.06±19.34 29.62±18.24 98.34*** A***, B***, C*

Higher PSQI scores denote lower sleep quality. Friedman’s test statistic (X2 F) was used to determine changes in PSQI and drug intake over time.

Abbreviations: Post-hoc differences are denoted as “A”: between Pre-Baseline and Exam Period, “B”: between Exam Period and Post-Baseline, and “C”: between Pre- and Post-Baseline. n.s.: not significant. * p<0.05, ** p<0.01, *** p<0.001.